decisionhealth Newsletters, Answer Books - 2017 Issue 1 (January)
Drug screens 2017
Subscribe or sign in to view the full article.
Article Overview
This article explains 2017 updates to Medicare and CPT drug screen reporting. It is relevant to laboratory and billing professionals who need to understand how the drug testing code landscape changed, which code sets were affected, and how payer transitions and revised descriptors may impact claims processing.
Why This Topic Matters
Drug screening reporting changed in ways that could affect claim submission, payer edits, and reimbursement workflow. The article helps coding and billing staff identify which code sets were updated and why the 2017 transition may have caused temporary denials or confusion.
Article Sections
-
Presumptive drug screens
This section covers the 2017 changes affecting presumptive drug testing and the related transition between Medicare and CPT code sets.
-
Definitive drug screens
This section covers the 2017 updates to definitive drug testing and the associated Medicare coding changes.
What You Will Learn
- How 2017 drug screen updates affected Medicare and CPT reporting
- Which broad drug testing categories were revised
- How payer transitions can affect billing workflow for laboratory services
- What kinds of coding changes were discussed for presumptive and definitive testing
Who Should Read This
- Medical coders
- Billing staff
- Compliance staff
- Laboratory professionals
- Practice managers
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com